Duane C, Glavey S, Quinn J, Murphy P. Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism. Haematologica; https://doi.org/10.3324/haematol.2025.287442 [Early view].